Donor Selection for Allogenic Hemopoietic Stem Cell Transplantation: Clinical and Ethical Considerations
Allogenic hematopoietic progenitor cell transplantation (allo-HSCT) is an established treatment for many diseases. Stem cells may be obtained from different sources: mobilized peripheral blood stem cells, bone marrow, and umbilical cord blood. The progress in transplantation procedures, the establis...
Saved in:
Main Authors: | Irene Riezzo, Natascha Pascale, Raffaele La Russa, Arcangelo Liso, Monica Salerno, Emanuela Turillazzi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2017/5250790 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hematopoietic Stem Cell Transplantation: A Bioethical Lens
by: Arcangelo Liso, et al.
Published: (2017-01-01) -
Discrimination of Anti-Donor Response in Allogeneic Transplantation Using an Alloreactive T-Cell Detection Assay
by: Ryosuke Arata, et al.
Published: (2025-01-01) -
Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor
by: Federico Meconi, et al.
Published: (2019-01-01) -
Regulatory T Cells in Allogeneic Stem Cell Transplantation
by: Maria Michael, et al.
Published: (2013-01-01) -
A 54-Year-Old Woman with Donor Cell Origin of Multiple Myeloma after Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of CML
by: Erika Maestas, et al.
Published: (2016-01-01)